Literature DB >> 8733820

Pre-clinical pharmacology of atypical antipsychotic drugs: a selective review.

H Y Meltzer1.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8733820

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN： 0960-5371


× No keyword cloud information.
  16 in total

Review 1.  Animal models of schizophrenia: a critical review.

Authors:  E R Marcotte; D M Pearson; L K Srivastava
Journal:  J Psychiatry Neurosci       Date:  2001-11       Impact factor: 6.186

Review 2.  Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap.

Authors:  Judith Pratt; Catherine Winchester; Neil Dawson; Brian Morris
Journal:  Nat Rev Drug Discov       Date:  2012-06-22       Impact factor: 84.694

3.  The future of pharmacotherapy for schizophrenia.

Authors:  John M Kane; Anil Malhotra
Journal:  World Psychiatry       Date:  2003-06       Impact factor: 49.548

4.  Spotlight on olanzapine in bipolar I disorder.

Authors:  Paul L McCormack; Lynda R Wiseman
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

5.  Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist.

Authors:  C Reavill; A Kettle; V Holland; G Riley; T P Blackburn
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

6.  Antagonism at serotonin 5-HT(2A) receptors modulates functional activity of frontohippocampal circuit.

Authors:  Alessandro Gozzi; Valerio Crestan; Giuliano Turrini; Marcel Clemens; Angelo Bifone
Journal:  Psychopharmacology (Berl)       Date:  2010-01-29       Impact factor: 4.530

7.  Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia.

Authors:  G D Honey; E T Bullmore; W Soni; M Varatheesan; S C Williams; T Sharma
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

8.  Quetiapine : A Review of its Use in Schizophrenia.

Authors:  N S Gunasekara; C M Spencer
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

9.  Ziprasidone.

Authors:  R Davis; A Markham
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

10.  Repeated administration of the novel antipsychotic olanzapine does not modulate NMDA-sensitive glutamate and 5HT2 serotonin receptors in rats.

Authors:  Ottavio Gandolfi; Manuela Voltattorni; Renato Gaggi; Rossella Dall'Olio
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-05-13       Impact factor: 3.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.